CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 604 enrolled
Drug / intervention
MIND Diet +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02817074
NCT02817074N/ACompleted
CompareCT.gov

MIND Diet Intervention to Prevent Alzheimer's Disease

Rush University Medical Center·interventional·Posted Jun 29, 2016·Updated Mar 23, 2022

In Brief

A clinical study evaluating MIND Diet and Mild Weight Loss for Cognitive Decline and 3 related conditions. Completed, enrolled 604 participants across 2 sites.

Detailed Summary

Phase III randomized controlled trial designed to test the effects of a 3-year intervention of the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) on cognitive decline and brain neurodegeneration among 600 individuals 65+ years without cognitive impairment who are overweight and have suboptimal diets.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Decline, Dementia, Alzheimer Disease, Vascular Dementia
CountriesUnited States
CollaboratorsHarvard School of Public Health (HSPH), Brigham and Women's Hospital, National Institute on Aging (NIA)

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 29, 2016
Enrollment StartJan 1, 2017
Primary CompletionJun 30, 2021
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 10.0 years ago

Interventions

MIND Dietbehavioral

3-year dietary counseling to adhere to the MIND diet and for mild weight loss

Mild Weight Lossbehavioral

3-year dietary counseling to reduce calorie intake by 250 kcal/day for mild weight loss